These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16457651)

  • 1. Genetically modified dendritic cells for cancer immunotherapy.
    Ribas A
    Curr Gene Ther; 2005 Dec; 5(6):619-28. PubMed ID: 16457651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically modified dendritic cells in cancer therapy: implications for transfusion medicine.
    Foley R; Tozer R; Wan Y
    Transfus Med Rev; 2001 Oct; 15(4):292-304. PubMed ID: 11668436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cell gene therapy.
    Onaitis M; Kalady MF; Pruitt S; Tyler DS
    Surg Oncol Clin N Am; 2002 Jul; 11(3):645-60. PubMed ID: 12487060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy.
    Dullaers M; Thielemans K
    J Gene Med; 2006 Jan; 8(1):3-17. PubMed ID: 16288497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene carriers and transfection systems used in the recombination of dendritic cells for effective cancer immunotherapy.
    Chen YZ; Yao XL; Tabata Y; Nakagawa S; Gao JQ
    Clin Dev Immunol; 2010; 2010():565643. PubMed ID: 21197274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo transfection and/or cross-priming of dendritic cells following DNA and adenoviral immunizations for immunotherapy of cancer--changes in peripheral mononuclear subsets and intracellular IL-4 and IFN-gamma lymphokine profile.
    Mincheff M; Altankova I; Zoubak S; Tchakarov S; Botev C; Petrov S; Krusteva E; Kurteva G; Kurtev P; Dimitrov V; Ilieva M; Georgiev G; Lissitchkov T; Chernozemski I; Meryman HT
    Crit Rev Oncol Hematol; 2001; 39(1-2):125-32. PubMed ID: 11418309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lentiviral vectors for anti-tumor immunotherapy.
    Breckpot K; Emeagi PU; Thielemans K
    Curr Gene Ther; 2008 Dec; 8(6):438-48. PubMed ID: 19075627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically engineered dendritic cell-based cancer vaccines (review).
    Bubeník J
    Int J Oncol; 2001 Mar; 18(3):475-8. PubMed ID: 11179474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses.
    Worgall S; Busch A; Rivara M; Bonnyay D; Leopold PL; Merritt R; Hackett NR; Rovelink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG
    J Virol; 2004 Mar; 78(5):2572-80. PubMed ID: 14963160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA and RNA modified dendritic cell vaccines.
    Morse MA; Lyerly HK
    World J Surg; 2002 Jul; 26(7):819-25. PubMed ID: 11948364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple antigen-targeted immunotherapy with alpha-galactosylceramide-loaded and genetically engineered dendritic cells derived from embryonic stem cells.
    Fukushima S; Hirata S; Motomura Y; Fukuma D; Matsunaga Y; Ikuta Y; Ikeda T; Kageshita T; Ihn H; Nishimura Y; Senju S
    J Immunother; 2009 Apr; 32(3):219-31. PubMed ID: 19242378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lentiviral vectors for cancer immunotherapy: transforming infectious particles into therapeutics.
    Breckpot K; Aerts JL; Thielemans K
    Gene Ther; 2007 Jun; 14(11):847-62. PubMed ID: 17361214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virological and preclinical characterization of a dendritic cell targeting, integration-deficient lentiviral vector for cancer immunotherapy.
    Odegard JM; Kelley-Clarke B; Tareen SU; Campbell DJ; Flynn PA; Nicolai CJ; Slough MM; Vin CD; McGowan PJ; Nelson LT; Ter Meulen J; Dubensky TW; Robbins SH
    J Immunother; 2015; 38(2):41-53. PubMed ID: 25658613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically modified tumour vaccines: an obstacle race to break host tolerance to cancer.
    Nawrocki S; Wysocki PJ; Mackiewicz A
    Expert Opin Biol Ther; 2001 Mar; 1(2):193-204. PubMed ID: 11727529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lentiviral vector-mediated autonomous differentiation of mouse bone marrow cells into immunologically potent dendritic cell vaccines.
    Koya RC; Kimura T; Ribas A; Rozengurt N; Lawson GW; Faure-Kumar E; Wang HJ; Herschman H; Kasahara N; Stripecke R
    Mol Ther; 2007 May; 15(5):971-80. PubMed ID: 17375074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adeno-associated virus type 2-mediated transduction of human monocyte-derived dendritic cells: implications for ex vivo immunotherapy.
    Ponnazhagan S; Mahendra G; Curiel DT; Shaw DR
    J Virol; 2001 Oct; 75(19):9493-501. PubMed ID: 11533211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer immunotherapy using gene-modified dendritic cells.
    Ribas A; Butterfield LH; Glaspy JA; Economou JS
    Curr Gene Ther; 2002 Feb; 2(1):57-78. PubMed ID: 12108974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors.
    Osada T; Nagaoka K; Takahara M; Yang XY; Liu CX; Guo H; Roy Choudhury K; Hobeika A; Hartman Z; Morse MA; Lyerly HK
    J Immunother; 2015 May; 38(4):155-64. PubMed ID: 25839441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of dendritic cells with interferon-gamma-inducible protein-10 gene to enhance vaccine potency.
    Kang TH; Bae HC; Kim SH; Seo SH; Son SW; Choi EY; Seong SY; Kim TW
    J Gene Med; 2009 Oct; 11(10):889-98. PubMed ID: 19618483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.